Last updated on February 2019

HELIX a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)


Brief description of study

The purpose of this study is to determine whether SYL1001 ophthalmic solution is safe and effective in the treatment of signs and symptoms of Dry Eye Disease.

Clinical Study Identifier: NCT03108664

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.